Literature DB >> 30350305

Dopamine promotes cathepsin B-mediated amyloid precursor protein degradation by reactive oxygen species-sensitive mechanism in neuronal cell.

Sanju Kumari1,2, Abhishek Mukherjee1, Chinmay K Mukhopadhyay3.   

Abstract

Recent literature suggested an important function of native amyloid precursor protein (APP) as amine oxidase implicating in protection of brain cells from catecholamine-induced toxicity. However, any role of catecholamines on regulation of native APP has not been explored. Here we report that dopamine (DA), one of the most prominent catecholamine neurotransmitters in brain, down-modulates native APP protein in several neuronal cell types. Using SH-SY5Y cells as model, we detected no alteration of transcript expression and unaffected translation suggested that DA might induce APP degradation. We actually found that DA treatment decreased the stability of APP. Lysosomal blockers inhibited DA-induced APP degradation, but specific proteasomal blocker failed to do so. We detected the role of cathepsin B in DA-induced APP degradation by using pharmacological inhibitor and specific siRNA. We also revealed that DA could increase cathepsin B expression at both transcript and protein levels. Using antioxidant N-acetyl cysteine, we detected increased level of reactive oxygen species generation that was found responsible for induced cathepsin B expression by DA and resultant APP degradation. Our study reveals the existence of reciprocal regulation of a catecholamine and an amine oxidase implicating in brain catecholamine homeostasis.

Entities:  

Keywords:  APP; Cathepsin B; Dopamine; Lysosomal degradation; Neuronal cell; Reactive oxygen species

Mesh:

Substances:

Year:  2018        PMID: 30350305     DOI: 10.1007/s11010-018-3460-3

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  32 in total

Review 1.  Structure and function of dopamine receptors.

Authors:  D Vallone; R Picetti; E Borrelli
Journal:  Neurosci Biobehav Rev       Date:  2000-01       Impact factor: 8.989

2.  Synapse formation and function is modulated by the amyloid precursor protein.

Authors:  Christina Priller; Thomas Bauer; Gerda Mitteregger; Bjarne Krebs; Hans A Kretzschmar; Jochen Herms
Journal:  J Neurosci       Date:  2006-07-05       Impact factor: 6.167

3.  Gonadal function in young women with Down syndrome.

Authors:  N Angelopoulou; V Souftas; A Sakadamis; C Matziari; V Papameletiou; K Mandroukas
Journal:  Int J Gynaecol Obstet       Date:  1999-10       Impact factor: 3.561

Review 4.  Dopamine in neurotoxicity and neuroprotection: what do D2 receptors have to do with it?

Authors:  Yuri Bozzi; Emiliana Borrelli
Journal:  Trends Neurosci       Date:  2006-01-27       Impact factor: 13.837

5.  Insulin-induced activation of hypoxia-inducible factor-1 requires generation of reactive oxygen species by NADPH oxidase.

Authors:  Sudipta Biswas; Manveen Kaur Gupta; Debasis Chattopadhyay; Chinmay K Mukhopadhyay
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-11-03       Impact factor: 4.733

6.  Targeting of cell-surface beta-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments.

Authors:  C Haass; E H Koo; A Mellon; A Y Hung; D J Selkoe
Journal:  Nature       Date:  1992-06-11       Impact factor: 49.962

Review 7.  Dopaminergic neurons.

Authors:  Shankar J Chinta; Julie K Andersen
Journal:  Int J Biochem Cell Biol       Date:  2004-12-02       Impact factor: 5.085

Review 8.  Dopamine: 50 years in perspective.

Authors:  Susan D Iversen; Leslie L Iversen
Journal:  Trends Neurosci       Date:  2007-03-26       Impact factor: 13.837

Review 9.  Oxygen radicals as key mediators in neurological disease: fact or fiction?

Authors:  B Halliwell
Journal:  Ann Neurol       Date:  1992       Impact factor: 10.422

Review 10.  Dopamine neuron systems in the brain: an update.

Authors:  Anders Björklund; Stephen B Dunnett
Journal:  Trends Neurosci       Date:  2007-04-03       Impact factor: 13.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.